Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.870
+0.040 (2.19%)
Jan 22, 2026, 2:35 PM EST - Market open
Vivos Therapeutics Employees
Vivos Therapeutics had 109 employees as of December 31, 2024. The number of employees decreased by 14 or -11.38% compared to the previous year.
Employees
109
Change (1Y)
-14
Growth (1Y)
-11.38%
Revenue / Employee
$158,872
Profits / Employee
-$156,908
Market Cap
17.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 109 | -14 | -11.38% | 109 | 0 |
| Dec 31, 2023 | 123 | -40 | -24.54% | 114 | 9 |
| Dec 31, 2022 | 163 | -4 | -2.40% | 154 | 9 |
| Dec 31, 2021 | 167 | 69 | 70.41% | 158 | 9 |
| Dec 31, 2020 | 98 | 14 | 16.67% | 93 | 5 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VVOS News
- 1 day ago - Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - GlobeNewsWire
- 6 days ago - Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - GlobeNewsWire
- 5 weeks ago - Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript - Seeking Alpha
- 5 weeks ago - Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan - GlobeNewsWire
- 2 months ago - Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 - GlobeNewsWire
- 2 months ago - Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call - GlobeNewsWire
- 2 months ago - Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha